(Q38135763)

29 August 2017

title

The role of adiponectin signaling in metabolic syndrome and cancer (English)

1 reference

29 August 2017

1 reference

Michael P Scheid

1

1 reference

29 August 2017

Gary Sweeney

series ordinal

2

1 reference

29 August 2017

language of work or name

1 reference

1 June 2014

1 reference

29 August 2017

number of pages

11

1 reference

Reviews in Endocrine and Metabolic Disorders

inferred from page(s)

published in

1 reference

29 August 2017

volume

15

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

157-167

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-013-9265-5

29 August 2017

exact match

0 references

cites work

Obesity and cancer risk: evidence, mechanisms, and recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Body fat distribution and risk of cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The adipocyte as an endocrine organ in the regulation of metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin and cardiovascular health: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Energy homoeostasis: The roles of adipose tissue-derived hormones, peptide YY and Ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

LKB1 and AMPK and the cancer-metabolism link - ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Analysis of the LKB1-STRAD-MO25 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Unravelling the activation mechanisms of protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

mTOR in aging, metabolism, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Coculture with primary visceral rat adipocytes from control but not streptozotocin-induced diabetic animals increases glucose uptake in rat skeletal muscle cells: role of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Metabolic syndrome and heart failure--the risk, paradox, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The obesity paradox in heart failure: accepting reality and making rational decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Cardiac remodeling in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin: mechanistic insights and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin receptor as a key player in healthy longevity and obesity-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The myocyte expression of adiponectin receptors and PPARδ is highly coordinated and reflects lipid metabolism of the human donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Opposing effects of adiponectin receptors 1 and 2 on energy metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Role of adiponectin in human skeletal muscle bioenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Exercise training performed simultaneously to a high-fat diet reduces the degree of insulin resistance and improves adipoR1-2/APPL1 protein levels in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Otto Warburg's contributions to current concepts of cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Molecular pathways: adiponectin and leptin signaling in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Overweight as an avoidable cause of cancer in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Serum adiponectin and leptin levels in Taiwanese breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Effects of adiponectin on breast cancer cell growth and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

LKB1, a protein kinase regulating cell proliferation and polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

The LKB1 tumor suppressor negatively regulates mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Tissue levels of adiponectin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9265-5

Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats

21 January 2018

1 reference

12 December 2020

Direct effects of adipokines on the heart: focus on adiponectin

1 reference

12 December 2020

Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling

1 reference

12 December 2020

Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes

1 reference

12 December 2020

Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway

1 reference

12 December 2020

Adiponectin action: a combination of endocrine and autocrine/paracrine effects.

1 reference

12 December 2020

Adiponectin: sometimes good, sometimes bad?

1 reference

12 December 2020

Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation

1 reference

12 December 2020

Association of serum adiponectin levels with breast cancer risk

1 reference

12 December 2020

Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice

1 reference

12 December 2020

Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha

1 reference

12 December 2020

Diet and Cancer: What's Next?

1 reference

12 December 2020

The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway

1 reference

12 December 2020

Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway

1 reference

12 December 2020

Adiponectin: regulation of its production and its role in human diseases

1 reference

12 December 2020

Effects of adiponectin and leptin co-treatment on human breast cancer cell growth.

1 reference

12 December 2020

Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol.

1 reference

12 December 2020

10.1007/S11154-013-9265-5

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1051744227

0 references

1 reference